Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
McKinsey
Colorcon
Baxter

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Keryx Biopharmaceuticals, Inc. v. Chemo Research S.L. (D. Del. 2019)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Keryx Biopharmaceuticals, Inc. v. Chemo Research S.L. (D. Del. 2019)

Docket   Start Trial Date Filed 2019-02-01
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties CHEMO RESEARCH S.L.; CHEN HSING HSU; INSUD PHARMA S.L.; INSUD PHARMA S.L.U.; KERYX BIOPHARMACEUTICALS, INC.; PANION & BF BIOTECH, INC.
Patents 7,767,851; 8,093,423; 8,299,298; 8,338,642; 8,609,896; 8,754,257; 8,754,258; 8,846,976; 8,901,349; 9,050,316; 9,328,133; 9,387,191; 9,757,416
Attorneys Adam C. LaRock; Anne Shea Gaza; Anthony David Raucci; Charles T. Wysocki; Dennies Varughese; Deric X. Geng, Ph.D.; Emily R. Whelan; Jack B. Blumenfeld; Katherine P. Kieckhafer; Kevin S. Prussia; Lisa J. Pirozzolo; Samantha G. Wilson; Timothy A. Cook
Firms Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Keryx Biopharmaceuticals, Inc. v. Chemo Research S.L.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Keryx Biopharmaceuticals, Inc. v. Chemo Research S.L. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 United States Patent Nos. 5,753,706 (the “’706 patent”); 7,767,851 (the “’851 patent”); 8,093,423 (the…(the “’423 patent”); 8,299,298 (the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896…’896 patent”); 8,754,257 (the “’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent…PageID #: 2 “’349 patent”); 9,050,316 (the “’316 patent”); 9,328,133 (the “’133 patent”); 9,387,191 (the…the “’191 patent”); and 9,757,416 (the “’416 patent”) (collectively, the “patents-in-suit”), owned by External link to document
0000-00-00 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,753,706 ;7,67,851 B2 ;8,093,423 B2 ;8,299,298… 1 February 2019 1:19-cv-00220 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Colorcon
Baxter
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.